Literature DB >> 20692359

Resveratrol and derivatives for the prevention and treatment of cancer.

Simone Fulda1.   

Abstract

Resveratrol, a naturally derived stilbene that exists in various foods and beverages, has attracted increasing attention over the past decade because of its multiple beneficial properties, including chemopreventive and antitumor activities. There are several other natural derivatives of resveratrol that are structurally similar to resveratrol and are also present in food. In addition, a series of resveratrol analogs have been synthesized by the addition of defined functional groups to increase the potency and/or enhance the activity of specific properties of resveratrol. Such resveratrol derivatives might provide promising tools as cancer chemopreventive agents, as well as cancer therapeutics in the prevention and treatment of cancer. This review provides an overview of key derivatives of resveratrol as cancer therapeutics.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692359     DOI: 10.1016/j.drudis.2010.07.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  55 in total

1.  Cloning a peanut resveratrol synthase gene and its expression in purple sweet potato.

Authors:  Li-Ping Pan; Si-Li Yu; Chang-Jian Chen; Hui Li; Yi-Liang Wu; Hai-Hang Li
Journal:  Plant Cell Rep       Date:  2011-09-20       Impact factor: 4.570

Review 2.  Resveratrol biosynthesis: plant metabolic engineering for nutritional improvement of food.

Authors:  Giovanna Giovinazzo; Ilaria Ingrosso; Annalisa Paradiso; Laura De Gara; Angelo Santino
Journal:  Plant Foods Hum Nutr       Date:  2012-09       Impact factor: 3.921

3.  Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.

Authors:  Wei Li; Jiguang Ma; Qingyong Ma; Bin Li; Liang Han; Jiangbo Liu; Qinhong Xu; Wanxing Duan; Shuo Yu; Fengfei Wang; Erxi Wu
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 4.  Diabetic complications in pregnancy: is resveratrol a solution?

Authors:  Chandra K Singh; Ambrish Kumar; Holly A Lavoie; Donald J Dipette; Ugra S Singh
Journal:  Exp Biol Med (Maywood)       Date:  2013-05-29

5.  Resveratrol-salicylate derivatives as selective DNMT3 inhibitors and anticancer agents.

Authors:  Fahad S Aldawsari; Rodrigo Aguayo-Ortiz; Kanishk Kapilashrami; Jakyung Yoo; Minkui Luo; José L Medina-Franco; Carlos A Velázquez-Martínez
Journal:  J Enzyme Inhib Med Chem       Date:  2015-06-29       Impact factor: 5.051

6.  4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.

Authors:  Amruta Ronghe; Anwesha Chatterjee; Bhupendra Singh; Prasad Dandawate; Fatma Abdalla; Nimee K Bhat; Subhash Padhye; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2016-03-09       Impact factor: 4.219

7.  A novel target for Huntington's disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology.

Authors:  László Bodai; J Lawrence Marsh
Journal:  Bioessays       Date:  2012-02       Impact factor: 4.345

8.  Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.

Authors:  Amruta Ronghe; Anwesha Chatterjee; Bhupendra Singh; Prasad Dandawate; Leigh Murphy; Nimee K Bhat; Subhash Padhye; Hari K Bhat
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-19       Impact factor: 4.292

9.  Two new cytotoxic stilbenoid dimers isolated from Cajanus cajan.

Authors:  Nenling Zhang; Xiangchun Shen; Xiaofei Jiang; Jiazhong Cai; Xiaoling Shen; Yingjie Hu; Samuel X Qiu
Journal:  J Nat Med       Date:  2017-10-12       Impact factor: 2.343

10.  Synthesis and Cytotoxicity of Semisynthetic Withalongolide A Analogues.

Authors:  Hashim F Motiwala; Joseph Bazzill; Abbas Samadi; Huaping Zhang; Barbara N Timmermann; Mark S Cohen; Jeffrey Aubé
Journal:  ACS Med Chem Lett       Date:  2013-11-14       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.